A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

Endogenous Retroviruses (ERVs), relics from ancient viral infections, form a significant part of vertebrate genomes, including humans, where they constitute ...

Medical oncologist (ex AstraZeneca, MorphoSys, Autolus Therapeutics) joins to advance Asgard’s lead asset AT-108 into Phase 1 ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

Dr. Lun Yu explains how advanced molecular design can enable peptides to target the biological roots of skin ageing, turning longevity science into actionable innovation ...

St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

The capacity of an organism to regenerate depends on cell dedifferentiation followed by proliferation. Mammals, in general, have limited regenerative capacity. Now, a team of researchers at the Salk ...

A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma. The discovery demonstrates a ...

One promising strategy to remuscularize the injured heart is the direct cardiac reprogramming of heart fibroblast cells into cardiomyocytes. Researchers have identified TBX20 as the key missing ...